Uwe Paasch
News
21.01.2021
Asclepion Laser Technologies: Innovative partner for your aesthetic practice
To develop innovative and successful products is the ethos of Asclepion Laser Technologies. Therefore, the company invests intensively in research and medical practice. The goal is to make the advantages […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
10.02.2025
Global Consensus for the Management of Acute Complications from Hyaluronic Acid Injections in Aesthetic Medicine
The increasing popularity of hyaluronic acid (HA) injections in aesthetic medicine is associated with rising numbers of cases of rare but serious vascular complications such as ischemia, necrosis, scarring, and […]

